Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hudecek

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Journal of Visualized Experiments : Jove|May 11, 2026
Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics AnalysisJulia Franz, Fabian Freitag, Patrick Ho, et al.
Critical Reviews in Biochemistry and Molecular Biology|April 13, 2017
Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical sideMichael Hudecek, Zsuzsanna Izsvák, Sandra Johnen, et al.
Cancers|December 24, 2021
Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid LeukemiaMarius Maucher, Micha Srour, Sophia Danhof, et al.
Frontiers in Immunology|January 11, 2021
Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management StrategiesXiang Zhou, Leo Rasche, K Martin Kortüm, et al.
Human Gene Therapy|September 11, 2023
Genome Editing in Engineered T Cells for Cancer ImmunotherapyChiara Bonini, Aude G Chapuis, Michael Hudecek, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 22, 2022
Minicircles for CAR T Cell Production by Sleeping Beauty Transposition: A Technological OverviewSabrina Prommersberger, Razieh Monjezi, Ram Shankar, et al.
Oncogene|February 21, 2024
Correction: ROR1-targeting switchable CAR-T cells for cancer therapyHaiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Cancer|February 7, 2018
Current developments in immunotherapy in the treatment of multiple myelomaMartin Köhler, Christine Greil, Michael Hudecek, et al.
Advanced Healthcare Materials|April 18, 2025
Short-Chain Fatty Acids Modulate Anti-ROR1 CAR T-Cell Function and Exhaustion in an Intestinal Adenocarcinoma-on-Chip ModelValentin D Wegner, Adrian Feile, Miriam Alb, et al.
Oncogene|July 21, 2022
ROR1-targeting switchable CAR-T cells for cancer therapyHaiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Journal of Visualized Experiments : Jove|May 11, 2026
Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics AnalysisJulia Franz, Fabian Freitag, Patrick Ho, et al.
Critical Reviews in Biochemistry and Molecular Biology|April 13, 2017
Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical sideMichael Hudecek, Zsuzsanna Izsvák, Sandra Johnen, et al.
Cancers|December 24, 2021
Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid LeukemiaMarius Maucher, Micha Srour, Sophia Danhof, et al.
Frontiers in Immunology|January 11, 2021
Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management StrategiesXiang Zhou, Leo Rasche, K Martin Kortüm, et al.
Human Gene Therapy|September 11, 2023
Genome Editing in Engineered T Cells for Cancer ImmunotherapyChiara Bonini, Aude G Chapuis, Michael Hudecek, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 22, 2022
Minicircles for CAR T Cell Production by Sleeping Beauty Transposition: A Technological OverviewSabrina Prommersberger, Razieh Monjezi, Ram Shankar, et al.
Oncogene|February 21, 2024
Correction: ROR1-targeting switchable CAR-T cells for cancer therapyHaiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Cancer|February 7, 2018
Current developments in immunotherapy in the treatment of multiple myelomaMartin Köhler, Christine Greil, Michael Hudecek, et al.
Advanced Healthcare Materials|April 18, 2025
Short-Chain Fatty Acids Modulate Anti-ROR1 CAR T-Cell Function and Exhaustion in an Intestinal Adenocarcinoma-on-Chip ModelValentin D Wegner, Adrian Feile, Miriam Alb, et al.
Oncogene|July 21, 2022
ROR1-targeting switchable CAR-T cells for cancer therapyHaiyong Peng, Thomas Nerreter, Katrin Mestermann, et al.
Pageof 14